CD44 and cholangiocarcinoma: Furthermore, the expression of the epithelial marker E-Cadherin increased but the expression of the mesenchymal markers N-Cadherin, CD44, Zeb1, and Vimentin (Marconi et al., 2021) were reduced with butyrate treatment in both CCA cell lines (Figures 2H,I).